Antigenics News - AGEN

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
Big Cap Pro
Monthly Subscription
for only
$47.31
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ and Amex.
Monthly Subscription
for only
$48.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Agenus Inc. AGEN NASDAQ Common Stock US00847G7051
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.14 +3.33% 4.35 4.37 4.03 4.16 4.21 20:00:00
more quote information »

Recent News

Date Time Source Heading
2/14/201814:53EDGARAmended Statement of Ownership (sc 13g/a)
2/12/201809:08EDGARStatement of Ownership (sc 13g)
2/01/201808:05IHNWTraders News Source Identifies four stocks to add to your..
1/29/201816:51EDGARAmended Statement of Ownership (sc 13g/a)
1/24/201816:15EDGARSecurities Registration Statement (simplified Form) (s-3)
1/22/201810:00PRNUSAgenus Announces Combination Clinical Trials of its..
1/22/201807:12EDGARCurrent Report Filing (8-k)
1/22/201807:00PRNUSAgenus Inc. Closes $230 Million Royalty Monetization with..
1/22/201806:02EDGARNotice of Effectiveness (effect)
1/19/201816:23EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
1/19/201816:18EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
1/08/201808:38EDGARCurrent Report Filing (8-k)
1/08/201808:32PRNUSAgenus Inc. Announces $230 Million Royalty Monetization with..
1/04/201816:16EDGARStatement of Changes in Beneficial Ownership (4)
1/04/201816:11EDGARStatement of Changes in Beneficial Ownership (4)
1/04/201816:06EDGARStatement of Changes in Beneficial Ownership (4)
1/04/201807:30PRNUSAgenus' Dr. John Castle Joins Thought Leadership Panel on..
1/03/201807:00PRNUSAgenus Announces Key Leadership to Advance Combination..
12/22/201716:06EDGARCurrent Report Filing (8-k)
12/14/201716:47EDGARStatement of Changes in Beneficial Ownership (4)
12/14/201716:39EDGARStatement of Changes in Beneficial Ownership (4)
12/14/201716:35EDGARStatement of Changes in Beneficial Ownership (4)
12/14/201716:28EDGARStatement of Changes in Beneficial Ownership (4)
12/14/201716:22EDGARStatement of Changes in Beneficial Ownership (4)
12/14/201716:16EDGARStatement of Changes in Beneficial Ownership (4)
12/04/201716:15EDGARStatement of Changes in Beneficial Ownership (4)
11/28/201706:50PRNUSStock Review for Biotech's Investors -- Spark Therapeutics,..
11/15/201716:07EDGARCurrent Report Filing (8-k)
11/15/201709:25PRNUSAgenus Receives License Fee of $4 Million USD from Merck
11/09/201716:22EDGARSecurities Registration Statement (simplified Form) (s-3)
11/09/201708:45PRNUSAgenus To Present on Lead Antibody Programs AGEN1884..
11/08/201714:12PRNUSAgenus to Present at the Jefferies Global Healthcare..
11/07/201717:09EDGARQuarterly Report (10-q)
11/07/201709:22PRNUSAgenus Reports Third Quarter 2017 Financial Results and..
10/31/201710:09EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
10/31/201706:01EDGARNotice of Effectiveness (effect)
10/30/201717:06EDGARStatement of Changes in Beneficial Ownership (4)
10/26/201712:40PRNUSAgenus to Report Third Quarter 2017 Financial Results on..
10/25/201716:24PRNUSShingrix with QS-21 Stimulon® Receives Positive..
10/23/201711:26PRNUSBruno Lucidi Appointed Chief Executive Officer of AgenTus..
10/23/201708:03PRNUSAgenus creates New Cell Therapy subsidiary named AgenTus..
10/20/201719:00PRNUSFDA Approves GSK's Shingles Vaccine with Agenus' QS-21..
10/18/201717:29EDGARSecurities Registration Statement (simplified Form) (s-3)
10/13/201714:09PRNUSGSK's Shingrix Containing Agenus' QS-21 Stimulon® Adjuvant..
10/04/201717:35EDGARStatement of Changes in Beneficial Ownership (4)
10/04/201717:30EDGARStatement of Changes in Beneficial Ownership (4)
10/04/201717:25EDGARStatement of Changes in Beneficial Ownership (4)
9/19/201707:00PRNUSAgenus to Present at Two Healthcare Investor Conferences In..
9/13/201715:53PRNUSGSK's Shingrix containing Agenus' QS-21 Stimulon® adjuvant..
9/13/201715:49PRNUSFDA Advisory Committee votes unanimously for Shingrix..
See more news about this stock »
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180218 19:51:19